Comparative Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Adult Attention-Deficit/Hyperactivity Disorder and comorbid depression (ASSURE-Extend) First published 02/03/2023 Last updated 31/05/2023 EU PAS number:EUPAS103757 Study Finalised